1. Home
  2. TARA vs CPZ Comparison

TARA vs CPZ Comparison

Compare TARA & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

N/A

Current Price

$7.26

Market Cap

268.5M

Sector

Health Care

ML Signal

N/A

Logo Calamos Long/Short Equity & Dynamic Income Trust

CPZ

Calamos Long/Short Equity & Dynamic Income Trust

N/A

Current Price

$14.88

Market Cap

297.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TARA
CPZ
Founded
N/A
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
268.5M
297.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TARA
CPZ
Price
$7.26
$14.88
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$21.00
N/A
AVG Volume (30 Days)
1.2M
63.0K
Earning Date
03-04-2026
01-01-0001
Dividend Yield
N/A
11.07%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.77
$13.17
52 Week High
$7.82
$16.11

Technical Indicators

Market Signals
Indicator
TARA
CPZ
Relative Strength Index (RSI) 70.06 42.96
Support Level $4.72 $14.81
Resistance Level $7.42 $15.11
Average True Range (ATR) 0.45 0.16
MACD 0.23 -0.02
Stochastic Oscillator 89.33 4.17

Price Performance

Historical Comparison
TARA
CPZ

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company that seeks to provide current income and risk-managed capital appreciation, with an investment objective to deliver total return through a combination of capital appreciation and current income. The Fund invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary, and others, and holds securities with a broad range of maturities, with the average term to maturity typically ranging from two to ten years. Managed assets represent the Fund's total assets, including any assets attributable to leverage that may be outstanding, minus total liabilities other than debt representing financial leverage.

Share on Social Networks: